Delivery Order SPE2DB22D1106-SPE2DB25FDYN6

Award Date 2/11/25
Potential Completion Date 2/12/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,943.71 firm fixed-price delivery order is for the supply of Piperacil-Tazo 3.375 gm additive vials, a specialty pharmaceutical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,313.72 firm fixed price delivery order is for PIPERACIL-TAZOBACT 3.375 GM VLS, a medical product. The contract has an ultimate completion date of April 20, 2023 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,566,436,607 units of the pharmaceutical product Piperacil-Tazobact 4.5 GM Vials. The firm-fixed-price delivery order, valued at $3,405.34, has an ultimate completion date of November 15, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,094.12 firm fixed-price delivery order contract is for the supply of Piperacillin-Tazobactam 3.375 gm vials, a critical antibiotic medication. The contract has a completion date of November 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,604.58 firm fixed-price delivery order contract is for the supply of Piperacillin-Tazobactam 3.375 gram vials, a critical injectable antibiotic medication. The contract has a period of performance through December 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,918.08 delivery order is for the supply of Piperacillin-Tazobactam 3.375 gm vials, a critical antibiotic medication. The contract has an ultimate completion date of April 27, 2023 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award, SPE2DB22D2006|SPE2DB25FV7UQ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,583.85, is a delivery order for the supply of 4567021627 PIPERACIL-TAZOBACT 3.375 GM VLS, a pharmaceutical product. The contract is a firm fixed-price arrangement with a completion date of January 24, 2025. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $2,767.92, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product PIPERACIL-TAZOBACT 3.375 GM VLS. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
This federal contract award is a delivery order (SPE2DX15D1022|SPE2DX25FUYNC) valued at $4,318.92 for the supply of the pharmaceutical product Piperacil-Tazobact 3.375 GM VLS. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor AmerisourceBergen Drug Corp, Corporate Office Division. This delivery order falls under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,074.15, is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical program, worth up to $999,999,999 through November 2026. This IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FDYN6
    Delivery Order

This federal contract award, with ID SPE2DB22D1106|SPE2DB25FDYN6, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,635.77 firm fixed-price delivery order covers the supply of Piperacil-Tazobact 3.375 GM VLS, a pharmaceutical product, to support military healthcare programs. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract does not have a set-aside designation, indicating open competition. As a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems, AmerisourceBergen plays a critical role in supplying a comprehensive range of pharmaceutical products and medical supplies to support the medical needs of service members, veterans, and other federal beneficiaries.

Generated 5/13/25, 10:06 AM